This section highlights three key biomarkers, short-chain fatty acids (SCFAs), calprotectin, and zonulin, that represent potential mechanistic links between gut dysbiosis and cardiovascular disease in the context of IBD (Table 2). This evidence concerns the gene HP and inflammatory bowel disease.